About Blog Welcome to the world's leading forum
on Multiple Sclerosis research, support, and knowledge.
Mountain View, CA About Blog Comprehensive up - to - date news coverage
on Multiple Sclerosis, aggregated from sources all over the world by Google News.
Find latest news and information
on Multiple Sclerosis.
Every year, a group of store employees participates as a team in a walk that raises money for research
on multiple sclerosis.
Find latest news and information
on Multiple Sclerosis.
My primary care provider introduced me to Rich Herbs Foundation and i immediately started
on their Multiple Sclerosis herbal formula treatment, this herbal treatment has made a tremendous difference for me.
On multiple sclerosis: «When I walk, I have to think about every single step, which is annoying and frustrating....
37/3: 00 Mendelian randomization provides evidence for a causal effect of low vitamin D
on multiple sclerosis risk: Results from the Kaiser Permanente MS Research Program.
The center will focus
on multiple sclerosis (MS), Alzheimer's disease, ALS (Lou Gehrig's disease), Parkinson's disease and brain tumors.
The center will focus
on multiple sclerosis (MS), Alzheimer's disease, ALS (Lou...
«My hope is that the progress we've made
on multiple sclerosis in the laboratory will one day lead to improvements in prevention, diagnosis, and treatment of all neurological diseases that involve blood clotting proteins in the brain.»
Akassoglou became interested in the convergence of these systems through her research
on multiple sclerosis (MS).
Dr. Akassoglou is a leader in the field of neurological disease, with a special emphasis
on multiple sclerosis (MS).
Not exact matches
«If we bring forward innovative drugs that make a difference in the lives of patients, they'll continue to get attractive pricing,» he says, noting Biogen's work
on potential breakthrough Alzheimer's and (additional)
multiple sclerosis meds.
Bourdette's paper focused
on Acthar as a treatment for
multiple sclerosis.
Teva beats first - quarter expectations but still has the same old problems Copaxone's market share and new generic launches helped Teva to forecast - beating profit and revenue but problems persistTeva had to make pricing concessions
on its flagship
multiple sclerosis drug Copaxone, and now expects a delay in approval of a key migraine drug, fremanezumab.
(Reuters)- Acorda Therapeutics Inc (ACOR.O) will cut nearly 20 percent of its workforce as part of a cost reduction plan, the company said
on Wednesday, less than a week after losing certain patents for its
multiple sclerosis (MS) drug, Ampyra.
Alkermes is partnering with Biogen
on ALKS 8700, a drug for
multiple sclerosis that improves
on Biogen's $ 4 billion Tecfidera, and a tolerability study should read out in the first half of 2018, with submission to the FDA expected in the the second half.
There is also an article
on the web — just type in — My Fight Against
Multiple Sclerosis by Roger MacDougall.
A woman suffering from
multiple sclerosis has lost an appeal to clarify the UK law
on assisted suicide.
When Spyer died two years later due to complications from a heart condition and a 30 - year battle with
multiple sclerosis, the US government refused to acknowledge the couple's marriage, forcing Windsor to pay more than $ 350,000 in federal taxes
on Spyer's estate — fees that heterosexual widows are generally exempt from.
Shares plummeted Tuesday by more than 90 percent
on a failed clinical trial for its
multiple sclerosis treatment.
Collins is the largest shareholder in that company, Innate Immunotherapeutics, which is working
on an experimental treatment for secondary progressive
multiple sclerosis.
When those same transcription factors land
on another part of the code, the risk of
multiple sclerosis appears to rise.
«The
multiple sclerosis drugs currently
on the market and being tested elsewhere seek to reduce the immune attack
on cells, but none target neurodegeneration nor do they work to restore nerve cell function.
Prior studies
on the diet have shown potential for alleviating symptoms of the neurodegenerative disease
multiple sclerosis, increasing the efficacy of chemotherapy for cancer treatments, and decreasing visceral fat.
Kessler Foundation researchers previously demonstrated that patients with
multiple sclerosis (MS) demonstrate worse cognition
on warmer days.
The special focus of the participating researchers is
on the treatment of
multiple sclerosis; however, they also hope to develop other fields of application for the N2B platform.
Kessler Foundation scientists correlated functional magnetic resonance imaging (fMRI) findings with the negative impact of outdoor temperature
on cognitive functioning in
multiple sclerosis (MS).
Multiple sclerosis on the other hand is more likely in younger adults, affecting between 2 and 150 people per 100,000.
That such vessels could have escaped detection when the lymphatic system has been so thoroughly mapped throughout the body is surprising
on its own, but the true significance of the discovery lies in the effects it could have
on the study and treatment of neurological diseases ranging from autism to Alzheimer's disease to
multiple sclerosis.
Although prior twin studies had hinted that nonheritable factors contribute to some autoimmune disorders, such as
multiple sclerosis, the recent analysis was one of the first to quantify genetic and environmental effects
on the general immune system.
However, around that time my Mum was diagnosed with
multiple sclerosis, and I became very interested in learning more about this disease and ways to treat it.In January 2002 I decided, after much thought, that I should change direction and study neuroscience, as the best thing I could do for MS patients is to work
on a cure.
«Blood clotting protein triggers immune attack
on brain: Disruption of the blood - brain barrier triggers a cascade of events that results in autoimmunity, brain damage characteristic of
multiple sclerosis.»
Dr. Quintana's research is focused
on the regulation of the adaptive and innate immune response and the identification of biomarkers for
multiple sclerosis (MS) and other immune - mediated diseases.
On the other hand, Sativex — a
multiple sclerosis medication not approved in the U.S. that GW Pharmaceuticals (where Russo worked for many years) started selling in the U.K. in 2010 — «has equal amounts of THC and CBD,» he adds.
The researchers from Bochum and Erlangen now plan to employ the gained insights to develop innovative dietary add -
on therapies to established immunotherapies in
multiple sclerosis.
«Our study adds to the body of data that support a favorable overall safety profile of the qHPV vaccine and expands
on this knowledge by providing comprehensive analyses of
multiple sclerosis and other demyelinating diseases.
A new study by Kessler Foundation scientists sheds light
on the mechanisms underlying cognitive fatigue in individuals with
multiple sclerosis.
The research focus within the medical community has increasingly centered
on the human intestine and its bacterial population, the so - called microbiome, especially in neurological disorders such as
multiple sclerosis.
«Working memory mediates the relationship between intellectual enrichment and long - term memory in
multiple sclerosis: An exploratory analysis of cognitive reserve» was published online ahead of print by the Journal of the International Neuropsychological Society
on July 14.
The study is investigator led and has therefore focused
on clinical need, targeting patients with progressive
multiple sclerosis in whom most disability is incurred... The study also reports a predominant effect
on neurodegenerative rather than inflammatory outcomes, suggesting a novel mechanism of action that might be suitable as combination treatment with immunomodulatory treatments... Further phase 3 studies to measure the effect of simvastatin
on sustained disability, particularly in patients with non-relapsing secondary progressive and primary progressive
multiple sclerosis, are clearly needed, but this trial represents a promising point from which to develop trials of progressive disease.»
Previous research has indicated that salt may alter the autoimmune response, which is implicated in the development of
multiple sclerosis (MS), but it is not clear if it has any direct effect
on the course of the disease itself.
A new technique that provides both chemical composition and molecular orientation information at subsecond timescales could reveal new information about what occurs
on the molecular level as diseases such as Alzheimer's and
multiple sclerosis progress.
«Exclusive breastfeeding and the effect
on postpartum
multiple sclerosis relapses.»
Adventurer Richard Gill sought relief from symptoms of
multiple sclerosis in an Ecuadorian tribal weapon — with wider results that live
on in medicine today
«Vaccines can be blamed for illness without scientific proof,» read many headlines about the European Court of Justice's (ECJ's) ruling
on the case of a French man who claimed that a hepatitis B vaccine caused his
multiple sclerosis (MS).
The study is «potentially groundbreaking,» says Tim Coetzee, a researcher at the National
Multiple Sclerosis Society who hopes the focus
on antioxidants could one day lead to new treatments.
A review of the literature
on treating
multiple sclerosis (MS) aims to provide physicians with evidence - based information
on the latest treatments for this chronic disease.
They also assist in the prevention of autoimmune diseases, such as diabetes (an immune attack
on the pancreas) and
multiple sclerosis (an immune attack
on the nerves).